Key result
Endothelial amyloid-β precursor protein deletion exacerbates aging-induced endothelial dysfunction and lowers eNOS expression in mice.
Why the study?
The physiological function of amyloid precursor protein in the control of endothelial function during aging is unclear.
Does endothelium-specific deletion of APP exacerbate aging-induced endothelial dysfunction in mice?
Does endothelium-specific deletion of APP exacerbate aging-induced endothelial dysfunction in mice?
Aging-induced upregulation of amyloid precursor protein in vascular endothelium appears to be an adaptive response that protects and preserves eNOS expression and endothelial function.
Suggests endothelial APP protects against age-related dysfunction in mice; hypothesis-generating for human vascular aging therapies.
The physiological function of amyloid precursor protein (APP) in the control of endothelial function during aging is unclear. Aortas of young (4-6 months old) and aged (23-26 months old) wild-type (WT) and endothelium-specific APP-deficient (eAPPâ/â) mice were used to study aging-induced changes in vascular phenotype. Unexpectedly, aging significantly increased protein expression of APP in aortas of WT mice but not in aortas of eAPPâ/â mice thereby demonstrating selective upregulation APP expression in vascular endothelium of aged aortas. Most notably, endothelial dysfunction (impairment of endothelium-dependent relaxations) induced by aging was significantly exacerbated in aged eAPPâ/â mice aortas as compared to age-matched WT mice. Consistent with this observations, endothelial nitric oxide synthase (eNOS) protein expression was significantly decreased in aged eAPPâ/â mice as compared to age matched WT mice. In addition, protein expression of cyclooxygenase 2 and release of prostaglandins were significantly increased in both aged WT and eAPPâ/â mice. Notably, treatment with cyclooxygenase inhibitor, indomethacin, normalized endothelium-dependent relaxations in aged WT mice, but not in aged eAPPâ/â mice. In aggregate, our findings support the concept that aging-induced upregulation of APP in vascular endothelium is an adaptive response designed to protect and preserve expression and function of eNOS.
No takes yet. Share an insight, caveat, or question.
d’Uscio et al. (2021) studied Endothelial dysfunction induced by aging. Endothelium-specific deletion of amyloid-β precursor protein vs. Wild-type mice was evaluated on Endothelial dysfunction (impairment of endothelium-dependent relaxations). Endothelium-specific deletion of amyloid-β precursor protein significantly exacerbated aging-induced endothelial dysfunction and decreased eNOS expression compared to wild-type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: